Trials / Completed
CompletedNCT06642480
Distribution of CYP2D6 Multiplication, CYP2D6*5, and Clinical Implications in Postoperative Patients Receiving Tramadol Analgesia in the Minangkabau Ethnic Group, Indonesia
Determination of Patients' Visual Analogue Scale (VAS) in Postoperative Patients Receiving Tramadol Analgesia in the Minangkabau Ethnic Group, Indonesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia · Other Government
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
Cytochrome P450 2D6 (CYP2D6) is an important enzyme in metabolizing commonly used drugs such as Tramadol hydrochloride (widely used opioid analgesic). Genetic polymorphisms of the CYP2D6 gene have been shown to influence the pharmacodynamic properties of the administered drug. This study aimed to screen 63 postoperative patients (wild-type, CYP2D6\*5, and CYP2D6 multiplication) of Minangkabau ethnicity in West Sumatera, Indonesia, who received tramadol using a modified long PCR method and to investigate the clinical impact of tramadol on the patients.
Detailed description
VAS of 63 patients was determined by injecting tramadol at a dose of 100 mg 30 minutes before the operation was completed. It was observed in the recovery room at 30, 60, and 120 minutes. Tramadol had an onset time of 15-60 minutes, with peak effectiveness at 2-6 hours postoperatively. Pain level was categorized into 0 (no pain), 1-3 (signifying mild), 4-6 (middle), and 7-10 ( heavy pain).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Post Operative Analgesia | administering 100 mg of intravenous tramadol 30 minutes before the operation is completed |
| DRUG | Post Operative Analgesia | VAS of 63 patients was determined by injecting tramadol at a dose of 100 mg 30 minutes before the operation was completed. It was observed in the recovery room at 30, 60, and 120 minutes. |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-03-01
- Completion
- 2023-03-01
- First posted
- 2024-10-15
- Last updated
- 2024-10-24
Locations
1 site across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT06642480. Inclusion in this directory is not an endorsement.